Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test

J Acquir Immune Defic Syndr. 2010 Jan;53(1):150-1. doi: 10.1097/QAI.0b013e3181c428b4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Drug Resistance, Viral / drug effects
  • Drug Resistance, Viral / genetics
  • Drug Resistance, Viral / physiology*
  • Female
  • HIV / drug effects*
  • HIV / genetics
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • Humans
  • Male
  • Middle Aged
  • Mutation / drug effects
  • Mutation / genetics*
  • Mutation / physiology
  • Nitriles
  • Pyridazines / therapeutic use*
  • Pyrimidines
  • Young Adult

Substances

  • Nitriles
  • Pyridazines
  • Pyrimidines
  • etravirine